BACKGROUND
Antiresorptive agents for the treatment of osteoporosis suppress bone remodeling and reestablish bone turnover at a lower rate to reduce bone loss. Recombinant teriparatide (human… (More)
Hashimoto's encephalopathy, first described in 1966, is still problematic in terms of its pathophysiology, diagnosis, and treatment. The syndrome is more common in women, and is associated with… (More)
CONTEXT
Atypical femoral fractures have rarely been reported in women taking bisphosphonates, but this is still a controversial issue. Data are derived mainly from observation studies because a post… (More)
Treatment of osteoporosis is aimed to prevent fragility fractures and to stabilize or increase bone mineral density. Several drugs with different efficacy and safety profiles are available. The… (More)
We investigated the association between pulse wave velocity (PWV) and HIV infection, antiretroviral treatment-related characteristics, viral load, immune status, and metabolic changes in a… (More)
UNLABELLED
Controversial data suggest that patients with type 2 diabetes mellitus have an increased risk of fractures despite having, in some studies, higher bone mineral density.
METHODS
The aim… (More)
Before the introduction of routine measurements of serum calcium in ambulatory services, PHTP (primary hyperparathyroidism) was symptomatic with classic bone disease (known as osteitis fibrosa… (More)
OBJECTIVE
To determine vitamin D (25OHD) status and its relationship with bone mineral density (BMD) in 93 postmenopausal women.
SUBJECTS AND METHODS
Patients were distributed in two groups: Group… (More)
Primary hyperparathyroidism often presents as an asymptomatic disorder. In our institution, routine serum calcium measurements have now been used as part of medical examination for 23 years. Out of… (More)
OBJECTIVE
The objective is to present an update on the diagnosis and treatment of hypovitaminosis D, based on the most recent scientific evidence.
MATERIALS AND METHODS
The Department of Bone and… (More)